Chinese recommendations for the implementation of bedside echocardiography and remote consultation in patients with coronavirus disease 2019

• Published in: Chinese medical journal 2020-12, Vol.133 (23), p.2847-2849
• Main Authors: Pei-Fang Wei, Echocardiography Group of Ultrasound Medicine Society of Chinese Medical Association, Cardiovascular Imaging Group of Cardiovascular Society of Chinese Medical Association, Echocardiography Society of Chinese College of Cardiovascular Physician of Chinese Medical Doctor Association, Ultrasound Medicine Committee of Chinese Medicine Education Association
• Format: Article
• Language: English
• Subjects: Cardiovascular disease; Coronaviruses; COVID-19; COVID-19 - diagnostic imaging; Echocardiography - methods; Heart failure; Hemodynamics; Hospitals; Humans; Hypertension; Intensive care; Medical diagnosis; Medical schools; Pulmonary arteries; Remote Consultation; SARS-CoV-2; Science; Ultrasonic imaging; Veins & arteries; Velocity
• ISSN: 0366-6999; 2542-5641
• DOI: 10.1097/CM9.0000000000001222

[2,3] The bedside echocardiography examination is the first-line preferential imaging option for the evaluation of myocarditis and other complications, such as acute right heart failure specially due to pulmonary artery embolism, stress cardiomyopathy, acute myocardial infarction and coexisting fundamental chronic cardiovascular disease. In the intensive care unit, the echocardiographic examination process and initial review are highly individual dependent with very limited time, and inconvenient echocardiographic examination conditions and views, which has been demonstrated that an unacceptable high rate of missed diagnosis and misdiagnosis occurred in the treatment of COVID-19. [...]the use of the 4G or 5G remote consultation platform during the COVID-19 outbreak period, which is fully aligned with the “Implementation protocol of lung ultrasound examination and remote consultation in patients of COVID-19 pneumonia,” can be helpful to achieve early and more effective multidisciplinary diagnosis and treatment for severe COVID-19 patients. Experts of Working Group Chun-Mei Li, University of Electronic Science and Technology Affiliated Hospital, Sichuan Provincial People's Hospital; Mei Zhang, Qilu Hospital, Shandong University; Shi-Hua Zhao, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; Ming-Xin Xie, Wuhan Union Hospital, Tongji Medical College of Huazhong University of Science and Technology; You-Bin Deng, Wuhan Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology; Qing Zhou, Renmin Hospital of Wuhan University and Hubei General Hospital; Jun Lin, Public Health Clinical Center of Chengdu; Jia-Wei Tian, The Second Affiliated Hospital, Harbin Medical University; Wen-Ping Wang, Zhongshan Hospital, Fudan University; Xiao-Dong Zhou, Xijing Hospital, Air Force Military Medical University; Jian-Chu Li, Peking Union Medical College Hospital; Xian-Hong Shu, Zhongshan Hospital, Fudan University; Hao Wang, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; Tian-Gang Zhu, Peking University People's Hospital; Wei-Dong Ren, First Hospital of China Medical University; Jian-Jun Yuan, Henan Provincial People's Hospital; Yu-Ming Mu, Xinjiang Medical University First Affiliated Hospital; Hong Tang, West China Hospital, Sichuan University; Di Xu, The First Affiliated Hospital of Nanjing Medical University and Jiangsu Province Hospital; Xiu-Zhang Lyu, Beijing Chao-Yan